secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2025-04-30T23:59:59+00:00
Accession:  0001217234-25-000036
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx Q1 revenue $84.7M (+18% YoY); GAAP net loss narrows to $10.4M; non-GAAP net income $5.4M
--------------------------------------------------------------------------------

- Revenue $84.7M (+18% YoY); testing services revenue $61.9M (+15%), volume ~47,100 (+12% YoY).
- GAAP net loss $10.4M ($0.19 loss per share) vs $19.9M ($0.38) prior year; non-GAAP net income $5.4M ($0.09 diluted).
- Adjusted EBITDA $4.6M vs loss $1.9M; cash $231M, no debt.
- Reaffirms FY2025 revenue guidance $365-375M, adjusted EBITDA $29-33M; 2027 targets $500M rev, $100M EBITDA.
- Launched AlloSure Heart for pediatric and AlloSure Kidney for SPK; presented AlloHeme data at TANDEM and EBMT.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723425000036/0001217234-25-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723425000036/cdna-20250430.htm
  HTML page:      https://secwatch.observer/filing/0001217234-25-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer